Company / Revenue per Share
ARS Pharmaceuticals, Inc. Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.86
FY2025
5-year range
$0.00 / $0.92
FY2021-FY2025
Trend
-6.9%
vs FY2024
Sector context
#108 of 154
Health Care
What the data says
At $0.86, ARS Pharmaceuticals, Inc.'s revenue per share ranks #108 of 154 in the Health Care sector. Improved from $0.00 to $0.86 over the past 2 years.
Based on SEC 10-K filings.
0.86 in FY2025 with a 3-year CAGR of +68.0%.
Improved from $0.00 to $0.86 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +68.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#108 of 154 in Health CareTop 70% of 154This company $0.86 Sector average $15.09
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 6.9% year-over-year.
- Ranks #108 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2024.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | -6.9% |
| FY2024 | $0.92 | +289445.4% |
| FY2023 | $0.00 | -99.8% |
| FY2022 | $0.18 | -4.9% |
| FY2021 | $0.19 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026